Ananya Kabi1, Ankita Kabi2 and Aroop Mohanty3*
1MBBS Student, Siksha ‘O’ Anusandhan Medical College, Bhubaneswar, Odisha, India
2Assistant Professor, Department of Emergency Medicine, AIIMS Rishikesh, Uttarakhand, India
3Assistant Professor, Department of Microbiology, AIIMS Gorakhpur, Uttar Pradesh, India
*Corresponding Author: Aroop Mohanty, Assistant Professor, Department of Microbiology, AIIMS Gorakhpur, Uttar Pradesh, India.
Received: September 13, 2021; Published: September 23, 2021
The COVID-19 pandemic has seen a major upsurge in the cases of Mucormycosis and has led to increased morbidity and mortality worldwide . Indiscriminate use of steroids in patients with uncontrolled diabetes and also use of humidifiers has further worsened the situation [2,3]. The treatment of mucormycosis is done taking into consideration a number of factors and includes the rectification of all the affecting and associated conditions, prompt administration of specific therapy and elimination of all affected tissue by surgery. India being the diabetic capital of the world, harbours a very susceptible population for the development of Mucormycosis. This makes it mandatory on our part to implement rapid correction of metabolic abnormalities in patients with uncontrolled diabetes mellitus . Various studies have postulated the use of sodium bicarbonate with insulin to correct ketoacidosis be it mild or severe in such patients.
Citation: Aroop Mohanty., et al. “Treatment Modalities for Mucormycosis: A Brief Insight".Acta Scientific Pharmacology 2.10 (2021): 24-25.
Copyright: © 2020 Aroop Mohanty., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.